Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | MRGPRX4 | Q96LA9 | 7/20 | 0.39 |
| ▸ | PPARD | Q03181 | 3/20 | 0.38 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.36 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18182409 | 0.92 | NR1H2 (0.41) | FFAR1FFAR4MRGPRX4PPARDNR1H2 | |
| SCHEMBL18182785 | 0.92 | MRGPRX4 (0.38) | FFAR1FFAR4MRGPRX4PPARDPTGER1 | |
| SCHEMBL18182486 | 0.92 | MRGPRX4 (0.38) | FFAR1FFAR4MRGPRX4PTGER1KCNK3 | |
| SCHEMBL18182372 | 0.92 | MRGPRX4 (0.38) | FFAR1FFAR4MRGPRX4PPARDPTGER1 | |
| SCHEMBL18156437 | 0.91 | FFAR1 (0.39) | FFAR1FFAR4MRGPRX4PPARDPTGER1 | |
| SCHEMBL18182950 | 0.89 | MRGPRX4 (0.42) | FFAR1FFAR4MRGPRX4NR1H2NR1H3 | |
| SCHEMBL18182349 | 0.89 | MRGPRX4 (0.42) | MRGPRX4KCNK3KCNK9 | |
| SCHEMBL18182350 | 0.89 | PTGER1 (0.38) | MRGPRX4PPARDPTGER1KCNK3KCNK9 | |
| SCHEMBL18182142 | 0.88 | MRGPRX4 (0.42) | MRGPRX4PPARA | |
| SCHEMBL18182946 | 0.88 | MRGPRX4 (0.42) | MRGPRX4PTGER1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9573904-B2 | Aromatic compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-21 | — | — | US | disclosed |
| US-20160311775-A1 | AROMATIC COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-10-27 | — | — | US | disclosed |
| EP-3081559-A1 | AROMATIC COMPOUND AND APPLICATION FOR SAME | Sumitomo Chemical Company, Limited (JP) | 2016-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311775-A1 | AROMATIC COMPOUND AND USE THEREOF | ZCCHC8, CBR3, CBX8 | FFAR1 2736/4885FFAR4 2485/4885MRGPRX4 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.